Table 4.
Factor | Responsive | Unresponsive | p-Value | OR | 95% CI of OR | |
---|---|---|---|---|---|---|
Lower | Upper | |||||
Gender, males | 21 (40.4%) | 11 (28.9%) | 0.265 | 1.663 | 0.680 | 4.063 |
Age, years | 46.75 ± 12.95 | 41.68 ± 17.3 | 0.117 | 1.023 | 0.994 | 1.053 |
Duration of eye symptoms, months | 8.75 [4–12]a | 24 [12–75] | 0.011 | 0.984 | 0.971 | 0.996 |
Smoking history | 28 (53.8%) | 19 (50%) | 0.718 | 1.167 | 0.505 | 2.696 |
Family history of TAO | 9 (17.3%) | 12 (31.6%) | 0.118 | 0.453 | 0.168 | 1.223 |
History of impaired thyroid function | 44 (84.6%) | 36 (94.7%) | 0.149 | 0.306 | 0.061 | 1.530 |
Pretreatment CAS | 4 [3–4] | 2 [1–3] | 0.001 | 1.653 | 1.214 | 2.250 |
Restoration of euthyroidism | 19 (36.5%) | 6 (15.8%) | 0.026 | 3.272 | 1.150 | 9.315 |
OR Odds ratio, CI confidence interval, TAO thyroid-associated ophthalmopathy, CAS clinical activity score, a[interquartile intervals, 25th–75th percentile]